ORGANIZATIONAL SKILLS INTERVENTION FOR ADHD CHILDREN

描述（申请人摘要）：除了ADHD的主要症状外， 一般认为，其他临床特征也是至关重要的， 组织任务和活动的问题，混乱的工作习惯，以及 倾向于丢失材料。一个著名的多动症模型认识到这些问题 反映了执行功能的缺陷。然而，系统的步骤 没有采取评估或干预措施，以改善组织，时间 管理和规划（OTMP）技能。本R21提交文件建议开发 改善8-11岁儿童OTMP技能缺陷的干预措施 注意力缺陷多动症该应用程序有三个主要目标：1）仪器开发; 2） 治疗开发;和3）试点干预试验。第一个目标是 开发OTMP技能的“真实的生活”措施，以：1）确定 （2）评估治疗效果。我们制定了两个评估策略： 儿童组织能力量表和儿童组织能力测验 组织技能。我们的第二个目标是开发一种手动干预 旨在通过改善OTMP技能来改善学校和家庭的功能。 我们的第三个目标是进行一项试点治疗研究，其中20名儿童是 分配至10周OTMP治疗组，20名分配至仅评估对照组 组试点研究旨在生成数据以估计效应量 进行全面的临床试验如果证明有效， 适当的研究设计，治疗旨在作为一个重要的 辅助其他有效的ADHD治疗方法。它是一种附属物， 目前还没有，所以这方面的创新似乎至关重要。

DESCRIPTION (Applicant's abstract): In addition to the cardinal signs of ADHD, it is generally recognized that other clinical features are crucial including problems in organizing tasks and activities, disorganized work habits, and a tendency to lose materials. A prominent model of ADHD recognizes these problems as reflecting deficits in executive functions. However, systematic steps have not been taken to assess or intervene in improving organizational, time management, and planning (OTMP) skills. This R21 submission proposes to develop an intervention to ameliorate the OTMP skill deficits in 8-11 year old children with ADHD. This application has three major aims: 1) instrument development; 2) treatment development; and 3) pilot intervention testing. The first aim is to develop "real life" measures of OTMP skills to: 1) identify specific areas of impairment; and 2) assess treatment outcome. We plan two assessment strategies: the Children's Organizational Skills Scale and the Analogue Test of Organization Skills. Our second aim is to develop a manualized intervention designed to improve functioning at school and home by ameliorating OTMP skills. Our third aim is to conduct a pilot treatment study in which 20 children are assigned to a 10-week OTMP treatment group and 20 to an assessment only control group. The pilot study is designed to generate data to estimate effect sizes needed to conduct a full-scale clinical trial. If proven effective in appropriate study designs, the treatment is intended to serve as an important adjunct to other validated treatments for ADHD. It is an adjunct that is currently missing, so innovation in this area seems crucial.